R. Lenzi et al., DETECTION OF PRIMARY BREAST-CANCER PRESENTING AS METASTATIC CARCINOMAOF UNKNOWN PRIMARY ORIGIN BY IN-111-PENTETREOTIDE SCAN, Annals of oncology, 9(2), 1998, pp. 213-216
Women with isolated metastatic carcinoma or adenocarcinoma involving a
xillary lymph nodes are a well-recognized group of unknown primary car
cnoma (UPC) patients with a favorable prognosis. This group of patient
s are generally treated based on the assumption that they have occult
breast cancer. However, to facilitate patient access to the whole spec
trum of therapies available for patients with breast cancer, including
strategies involving the use of high-dose chemotherapy, a precise dia
gnosis is increasingly important. In this clinical case we report the
detection of a primary breast cancer by In-111-pentetreotide scanning
in a woman who presented with metastatic carcinoma in axillary nodes,
no palpable breast lesion, a nondiagnostic mammogram, and negative bre
ast ultrasonography. Previous outcomes analysis of patients with UPC h
ave emphasized the value of identifying women with breast cancer. This
report suggests that the In-111-pentetreotide scan can contribute spe
cific, clinically useful information in the evaluation cf women presen
ting with metastatic carcinoma in axillary nodes and an occult primary
and deserves prospective study in women with UPC presenting with isol
ated axillary metastases.